• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

hyperkalaemia - Articles and news items

FDA to re-review application for AstraZeneca’s hyperkalaemia treatment

Industry news / 18 October 2016 / Niamh Louise Marriott, Digital Content Producer

Hyperkalaemia (potassium levels > 5.0 mEq/L in the blood serum) occurs in patients with advanced chronic kidney disease and chronic heart failure…

 

Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +